Delivery Order SPE2DB20D2104-SPE2DB25FMUJK

Award Date 6/30/25
Potential Completion Date 7/1/25
Potential Value $6.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $7,837.41 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of XELJANZ XR 11 MG TABLET UU 30S, a prescription medication. The contract has an ultimate completion date of May 28, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,084.42, is for the delivery of XELJANZ XR 11 MG TABLET UU 30S, a prescription medication. The contract has a period of performance through April 17, 2025 and is a firm fixed-price, non-set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply XELJANZ XR 11 MG TABLET for $16,370.67. The contract has a firm fixed price and a completion date of September 18, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $35,395.89, is for the delivery of XELJANZ XR 11 MG TABLET UU 30S and has an ultimate completion date of April 1, 2025. The contract is a firm-fixed-price type and was not set aside for any specific business category. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This is a firm-fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,616.45, is for the supply of XELJANZ XR 11 MG TABLET UU 30S, a prescription medication. The contract has an ultimate completion date of March 3, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of XELJANZ XR 11 MG TABLET, a prescription medication, with a ceiling value of $13,426.58 and a performance period through May 14, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of XELJANZ XR 11 MG TABLET UU 30S, a prescription medication, with a ceiling value of $6,596.48 and a period of performance through June 4, 2025. The contract is a firm fixed-price delivery order and is not set aside for any socioeconomic program. Amerisourcebergen Drug Corp holds a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $44,172.34, is for the delivery of XELJANZ XR 11 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of June 23, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of XELJANZ XR 11 MG TABLET, a medication, with a ceiling value of $5,922.73 and a period of performance through July 2, 2025. The contract is a firm fixed-price type and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $15,793.76, is for the supply of XELJANZ XR 11 MG tablets. The order has a completion date of May 13, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB25FMUJK
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of XELJANZ XR 11 MG TABLET UU 30S, a prescription medication. The contract has a firm fixed price of $6,437.93 and a completion date of July 1, 2025. The contract is not set aside and allows for the delivery of a variety of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026.

Generated 10/5/25, 1:03 AM